Porównaj metody

	EORTC QLQ-C30	Kwestionariusz Kontroli Astmy
Dziedzina	Wyniki zdrowotne	Wyniki zdrowotne
Rodzina	Process / pipeline	Process / pipeline
Rok powstania	1993	2004
Twórca	Nico Aaronson et al.	Robert A. Nathan et al.
Typ	Self-report quality of life questionnaire	Self-report symptom control questionnaire
Źródło pierwotne	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.	Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., ... & Pendergraft, T. B. (2004). Development of the asthma control test: A survey for assessing asthma control in children and adults. Allergy and Asthma Proceedings, 25(1), 1-6.
Inne nazwy	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale	ACT, Asthma Control Test, Asthma Control Assessment
Pokrewne	5	4
Podsumowanie	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.	The ACT is a simple, rapid, patient-centered measure of asthma control. Developed by Robert Nathan and colleagues in 2004, this 5-item questionnaire quantifies how asthma symptoms, activity limitation, and nighttime awakening affect daily life. It is the most widely used asthma control measure in clinical practice and is recommended by major asthma guidelines as a standard assessment tool.